SKI Market

Indian Indices

Sensex

83,029.69 -540.66
( -0.65%)

Global Indices

Nasdaq

49,379.59 -83.86
(-0.17%)

Dow Jones

6,960.70 -4.77
(-0.07%)

Hang Seng

53,565.61 -370.56
(-0.69%)

Nikkei 225

10,219.48 -19.46
(-0.19%)

Forex

USD-INR

90.32 0.07
(0.08%)

EUR-INR

104.98 -0.13
(-0.12%)

GBP-INR

121.10 -0.20
(-0.16%)

JPY-INR

0.57 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Prozone Realty Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

534675

INE195N01013

55.9435256

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PROZONER

420.23

833.65

EPS(TTM)

Face Value()

Div & Yield %

0.13

Back

Bafna Pharmaceuticals standalone net profit rises 19.08% in the September 2025 quarter

Nov 12,2025

Net profit of Bafna Pharmaceuticals rose 19.08% to Rs 3.12 crore in the quarter ended September 2025 as against Rs 2.62 crore during the previous quarter ended September 2024. Sales declined 12.03% to Rs 35.47 crore in the quarter ended September 2025 as against Rs 40.32 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	35.47	40.32	-12
OPM %	12.04	9.42	-
PBDT	4.59	4.20	9
PBT	3.12	2.62	19
NP	3.12	2.62	19

83,029.69 -540.66 ( -0.65%)

49,379.59 -83.86 (-0.17%)

6,960.70 -4.77 (-0.07%)

53,565.61 -370.56 (-0.69%)

10,219.48 -19.46 (-0.19%)

90.32 0.07 (0.08%)

104.98 -0.13 (-0.12%)

121.10 -0.20 (-0.16%)

0.57 0.00 (0.21%)